Biotechs as we all know cycle up down so one needs patience or could end up a patient , with PTX the buy/sell spread can be up to 10% so with volatile market days and low liquidity the price can get beaten up on not much money traded.
We still have muliple trials running with PTX-200 and soon going to start with PTX-100 .
We are looking to cure people who are resistant to current treatments and where there are no treatments.
Big valuations are given to these type of biotech companies . Out of all our trials running and yet to start i believe we will have success with a few of them.
